Michael S. Nakazawa
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism 6
- Cancer-related molecular mechanisms research 2
- MicroRNA in disease regulation 2
- Oncology top 10%
- Vascular Tumors and Angiosarcomas 3
- Cell Biology top 10%
-
- Sarcoma Diagnosis and Treatment 8
-
- Autophagy in Disease and Therapy 3
-
- Neuroblastoma Research and Treatments 3
-
- Cardiac tumors and thrombi 2
- Co-authors
- M. Celeste SimonBrian KeithT.S. Karin Eisinger‐MathasonSam S. YoonNicolas SkuliVera MucajNavid SadriJessica E.S. Shay
- Partner nations
- United StatesFranceSlovakia
In The Last Decade
Michael S. Nakazawa
15 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 87
- Cancer Research 539
- Oncology 340
- Molecular Biology 649
- Cell Biology 142
- Pulmonary and Respiratory Medicine 271
Countries citing papers authored by Michael S. Nakazawa
This map shows the geographic impact of Michael S. Nakazawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael S. Nakazawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael S. Nakazawa more than expected).
Fields of papers citing papers by Michael S. Nakazawa
This network shows the impact of papers produced by Michael S. Nakazawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael S. Nakazawa. The network helps show where Michael S. Nakazawa may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Michael S. Nakazawa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 3 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 4 | |
| 6 | 2023 | 5 | |
| 7 | 2017 | 36 | |
| 8 | 2016 | 58 | |
| 9 | 2016 | 332 | |
| 10 | 2015 | 35 | |
| 11 | 2015 | 81 | |
| 12 | 2014 | 53 | |
| 13 | 2013 | 308 | |
| 14 | 2013 | 213 | |
| 15 | 2013 | 39 | |
| 16 | 2013 | 4 | |
| 17 | 2012 | 34 |
About Michael S. Nakazawa
Michael S. Nakazawa is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Oncology, having authored 17 papers that have together received 1.2k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (8 papers), Cancer, Hypoxia, and Metabolism (6 papers), Vascular Tumors and Angiosarcomas (3 papers), Autophagy in Disease and Therapy (3 papers), Neuroblastoma Research and Treatments (3 papers), Cancer-related molecular mechanisms research (2 papers), Cardiac tumors and thrombi (2 papers) and MicroRNA in disease regulation (2 papers). The work is most often cited by research in Cancer Research (539 citations), Oncology (340 citations) and Molecular Biology (649 citations). Michael S. Nakazawa has collaborated with scholars based in United States, France and Slovakia. Frequent co-authors include M. Celeste Simon, Brian Keith, T.S. Karin Eisinger‐Mathason, Sam S. Yoon, Nicolas Skuli, Vera Mucaj, Navid Sadri, Jessica E.S. Shay, John M. Maris and Giordano Caponigro.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.